PTPRB and neoplasm: Our findings using a human cell-based platform demonstrate that pharmacological inhibition of VE-PTP in the VMT can restore the structure and function of tumor vessels through upregulation of Tie2, leading to increased sensitivity of TNBC to low-dose chemotherapy with paclitaxel.